QL
AGIO icon

Quarry LP’s Agios Pharmaceuticals AGIO Stock Holding History

Quarry LP’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Buy
+20,147
New +$611K 0.06% 109
2026
Q1 		– Sell
-3,000
Closed -$81.7K – 1388
2025
Q4 		$81.7K Sell
3,000
-2,000
-40% -$70.2K 0.01% 508
2025
Q3 		$201K Buy
+5,000
New +$188K 0.04% 353

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Quarry LP's AGIO Position: Q2 2026 in Review

Quarry LP opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 20,147 shares worth $748K. The stake represents 0.06% of the portfolio and ranks #109 among its holdings. This is a return to the name: Quarry LP previously reported a position in AGIO as recently as Q4 2025.

Quarry LP first reported a position in AGIO in Q3 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Quarry LP held 20,147 shares of Agios Pharmaceuticals worth $748K as of Q2 2026.
  • Agios Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Agios Pharmaceuticals made up 0.06% of Quarry LP's portfolio in Q2 2026, its #109 holding.
  • Quarry LP first reported a position in Agios Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.